Zhejiang Tianyu Pharmaceutical (300702.SZ)Pregabalin Capsules Obtained Drug Registration Certificate
Tianyu Group (300702.SZ) announced that its wholly-owned subsidiary Zhejiang Nuode Pharmaceutical Co., Ltd. (referred to as "Nuode...
Zhejiang Tianyu Pharmaceutical (300702.SZ) announced that its wholly-owned subsidiary Zhejiang Nuode Pharmaceutical Co., Ltd. (referred to as "Nuode Pharmaceutical") recently received the "Drug Registration Certificate" issued by the National Medical Products Administration for Prugabalin Capsules.
The announcement stated that Prugabalin Capsules are used to treat postherpetic neuralgia and fibromyalgia, a medication for postherpetic neuralgia.
Related Articles
RUIHE DATA (03680) plans to establish a limited partnership.
US Stock Market Move | SpaceX (SPCX.US) rose over 8%. The unlock of restricted shares did not lead to selling pressure, and short covering pushed the stock price up.
MEMESTRATEGY (02440) issues a profit warning, expecting a mid-term net loss of no less than 65 million yuan.
RUIHE DATA (03680) plans to establish a limited partnership.
US Stock Market Move | SpaceX (SPCX.US) rose over 8%. The unlock of restricted shares did not lead to selling pressure, and short covering pushed the stock price up.
MEMESTRATEGY (02440) issues a profit warning, expecting a mid-term net loss of no less than 65 million yuan.
RECOMMEND
